Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-024286
Filing Date
2023-05-25
Accepted
2023-05-25 17:00:36
Documents
1
Period of Report
2023-05-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 15712
  Complete submission text file 0000950170-23-024286.txt   17059
Mailing Address C/O ESPERION THERAPEUTICS, INC. 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address
Ignelzi Troy A. (Reporting) CIK: 0001579829 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38958 | Film No.: 23961816

Mailing Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110
Business Address 99 HIGH STREET 26TH FLOOR BOSTON MA 02110 857-449-2244
Karuna Therapeutics, Inc. (Issuer) CIK: 0001771917 (see all company filings)

EIN.: 270605902 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations